Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Business
Corp. News
Latest Headlines
Biotech
Investors
Stock Alerts
IPOs
M&A
Top Stories
Breaking News
Earnings
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Crypto
Cryptocurrency
Blockchain
Markets
Market News
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
US
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health News
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment News
Top Stories
Music News
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium
Intelligent Investor
Biotech Investor
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Roche Holding Ag (RO.SW)
Roche To Showcase Broad Ophthalmology Data Portfolio At ARVO 2026, Today
5/4/2026 4:26:25 AM
Roche Q1 Sales Down; Sees Full-Year Sales Growth At Constant Exchange Rates
4/23/2026 1:42:19 AM
Roche Q1 Sales CHF 14.722 Bln Vs. CHF 15.440 Bln Last Year
4/23/2026 1:14:00 AM
Roche's ENSPRYNG Cuts Relapse Risk In Rare Neurological Disease
4/22/2026 5:36:55 AM
Genentech's Fenebrutinib Slashes Relapses By Over 50% In RMS , But Safety Signals Cast A Shadow
4/22/2026 2:35:41 AM
Genentech : Phase III METEOROID Study Shows Enspryng Cuts Relapse Risk By 68% In MOGAD
4/21/2026 11:16:16 PM
Genentech Phase III FENhance Trials Show Fenebrutinib Cuts Relapse Rates By Over 50% In RMS
4/21/2026 11:05:42 PM
Roche's Gazyva/Gazyvaro SBLA For SLE Accepted By FDA; Decision Slated For December 2026
4/21/2026 6:56:01 AM
Genentech's Gazyva SBLA For Systemic Lupus Erythematosus Accepted By FDA; Decision Due Dec 2026
4/21/2026 1:33:07 AM
FDA Accepts Genentech’s SBLA For Gazyva In Systemic Lupus Erythematosus
4/21/2026 1:13:30 AM
Roche Wins CE Mark For Elecsys NfL Blood Test To Detect Neuroinflammation In MS Patients
4/13/2026 1:51:16 AM
Roche Secures CE Mark For Elecsys NfL Blood Test To Advance MS Neuroinflammation Detection
4/13/2026 1:32:02 AM
C4 Therapeutics Enters Collaboration Agreement With Roche
4/9/2026 7:52:22 AM
C4 Therapeutics Announces New Collaboration With Roche To Develop Innovative Cancer Treatments
4/9/2026 7:08:48 AM
Roche Announces Launch Of Cobas MPX-E Assay
3/30/2026 1:31:48 AM
Roche Launches Cobas MPX-E Assay In CE Mark Countries For HIV And Hepatitis Virus Detection
3/30/2026 1:14:06 AM
Roche Launches Cobas Eplex Respiratory Pathogen Panel 3
3/24/2026 2:03:40 AM
Roche Expands AI Power With NVIDIA Blackwell GPUs
3/16/2026 10:04:52 PM
Roche Secures CE Mark For First Blood Test To Identify ApoE4 Carriers In Alzheimer's Disease
3/16/2026 4:59:26 AM
Roche Wins CE Mark For Elecsys ApoE4 Blood Test To Detect Alzheimer's Disease Risk Variant
3/16/2026 2:23:25 AM
1
2
Next
»